Literature DB >> 22014068

S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis.

Aldo A Rodriguez-Menchaca1, Ernesto Solis, Krasnodara Cameron, Louis J De Felice.   

Abstract

BACKGROUND AND
PURPOSE: Wherever they are located, dopamine transporters (DATs) clear dopamine (DA) from the extracellular milieu to help regulate dopaminergic signalling. Exposure to amphetamine (AMPH) increases extracellular DA in the synaptic cleft, which has been ascribed to DAT reverse transport. Increased extracellular DA prolongs postsynaptic activity and reinforces abuse and hedonic behaviour. EXPERIMENTAL APPROACH: Xenopus laevis oocytes expressing human (h) DAT were voltage-clamped and exposed to DA, R(-)AMPH, or S(+)AMPH. KEY
RESULTS: At -60mV, near neuronal resting potentials, S(+)AMPH induced a depolarizing current through hDAT, which after removing the drug, persisted for more than 30 min. This persistent leak in the absence of S(+)AMPH was in contrast to the currents induced by R(-)AMPH and DA, which returned to baseline immediately after their removal. Our data suggest that S(+)AMPH and Na(+) carry the initial S(+)AMPH-induced current, whereas Na+ and Cl(-) carry the persistent leak current. We propose that the persistent current results from the internal action of S(+)AMPH on hDAT because the temporal effect was consistent with S(+)AMPH influx, and intracellular S(+)AMPH activated the effect. The persistent current was dependent on Na(+) and was blocked by cocaine. Intracellular injection of S(+)AMPH also activated a DA-induced persistent leak current. CONCLUSIONS AND IMPLICATIONS: We report a hitherto unknown action of S(+)AMPH on hDAT that potentially affects AMPH-induced DA release. We propose that internal S(+)AMPH acts as a molecular stent that holds the transporter open even after external S(+)AMPH is removed. Amphetamine-induced persistent leak currents are likely to influence dopaminergic signalling, DA release mechanisms, and amphetamine abuse.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22014068      PMCID: PMC3423253          DOI: 10.1111/j.1476-5381.2011.01728.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

Review 1.  Transporters as channels.

Authors:  Louis J DeFelice; Tapasree Goswami
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

Review 2.  The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits.

Authors:  Trent J Volz; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurochem       Date:  2007-01-23       Impact factor: 5.372

3.  The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site.

Authors:  Lei Shi; Matthias Quick; Yongfang Zhao; Harel Weinstein; Jonathan A Javitch
Journal:  Mol Cell       Date:  2008-06-20       Impact factor: 17.970

4.  Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopy.

Authors:  Cheryse A Furman; Rong Chen; Bipasha Guptaroy; Minjia Zhang; Ronald W Holz; Margaret Gnegy
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

5.  Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission.

Authors:  Lucia Carvelli; Randy D Blakely; Louis J DeFelice
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

6.  Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function.

Authors:  Kevin Erreger; Christof Grewer; Jonathan A Javitch; Aurelio Galli
Journal:  J Neurosci       Date:  2008-01-23       Impact factor: 6.167

7.  Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: evidence for differential regulation in caudate putamen and nucleus accumbens.

Authors:  Devadoss J Samuvel; Lankupalle D Jayanthi; Senthilvelan Manohar; Kolanjiappan Kaliyaperumal; Ronald E See; Sammanda Ramamoorthy
Journal:  J Pharmacol Exp Ther       Date:  2008-01-15       Impact factor: 4.030

8.  The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter.

Authors:  Jufang Shan; Jonathan A Javitch; Lei Shi; Harel Weinstein
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

9.  Neurotransmitter/sodium symporter orthologue LeuT has a single high-affinity substrate site.

Authors:  Chayne L Piscitelli; Harini Krishnamurthy; Eric Gouaux
Journal:  Nature       Date:  2010-12-23       Impact factor: 49.962

10.  Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue.

Authors:  Yongfang Zhao; Daniel S Terry; Lei Shi; Matthias Quick; Harel Weinstein; Scott C Blanchard; Jonathan A Javitch
Journal:  Nature       Date:  2011-04-24       Impact factor: 49.962

View more
  19 in total

1.  Comments on 'A quantitative model of amphetamine action on the serotonin transporter', by Sandtner et al., Br J Pharmacol 171: 1007-1018.

Authors:  Louis J De Felice; Krasnodara N Cameron
Journal:  Br J Pharmacol       Date:  2015-10       Impact factor: 8.739

2.  N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse Liability.

Authors:  Ernesto Solis; John S Partilla; Farhana Sakloth; Iwona Ruchala; Kathryn L Schwienteck; Louis J De Felice; Jose M Eltit; Richard A Glennon; S Stevens Negus; Michael H Baumann
Journal:  Neuropsychopharmacology       Date:  2017-05-22       Impact factor: 7.853

3.  Structural analysis of dopamine- and amphetamine-induced depolarization currents in the human dopamine transporter.

Authors:  Qiong-Yao Tang; Renata Kolanos; Louis J De Felice; Richard A Glennon
Journal:  ACS Chem Neurosci       Date:  2015-02-23       Impact factor: 4.418

Review 4.  Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder.

Authors:  Matthew L Banks
Journal:  Ann N Y Acad Sci       Date:  2016-12-09       Impact factor: 5.691

5.  "Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.

Authors:  Sean B Dolan; Zhenglan Chen; Renqi Huang; Michael B Gatch
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

6.  Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing.

Authors:  Kaustuv Saha; Danielle Sambo; Ben D Richardson; Landon M Lin; Brittany Butler; Laura Villarroel; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

7.  Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.

Authors:  Krasnodara Cameron; Renata Kolanos; Rakesh Vekariya; Rakesh Verkariya; Louis De Felice; Richard A Glennon
Journal:  Psychopharmacology (Berl)       Date:  2013-01-31       Impact factor: 4.530

8.  Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.

Authors:  Ernesto Solis
Journal:  Curr Top Behav Neurosci       Date:  2017

Review 9.  Chloride requirement for monoamine transporters.

Authors:  Louis J De Felice
Journal:  Pflugers Arch       Date:  2016-01-22       Impact factor: 3.657

10.  Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.

Authors:  Krasnodara N Cameron; Renata Kolanos; Ernesto Solis; Richard A Glennon; Louis J De Felice
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.